Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Distributed Loads: Problem Solving01:21

Distributed Loads: Problem Solving

Beams are structural elements commonly employed in engineering applications requiring different load-carrying capacities. The first step in analyzing a beam under a distributed load is to simplify the problem by dividing the load into smaller regions, which allows one to consider each region separately and calculate the magnitude of the equivalent resultant load acting on each portion of the beam. The magnitude of the equivalent resultant load for each region can be determined by calculating...
Method of Sections: Problem Solving I01:27

Method of Sections: Problem Solving I

Consider a symmetrical roof truss structure, composed of vertical, diagonal, and horizontal members. The length of each horizontal member is 4 m. The lengths of the vertical members FB and HD are 4 m, while the length of member GC is 6 m. The loads acting at joints F, G, and H are 2 kN, while those at joints A and E are 1 kN.
Method of Sections: Problem Solving II01:30

Method of Sections: Problem Solving II

Consider an arbitrary truss structure composed of diagonal, vertical, and horizontal members fixed to the wall. To calculate the force acting on members CB, GB, and GH, method of sections can be used. The loads and lengths of the horizontal and vertical members are known parameters, as shown in the figure.
Rolling Resistance: Problem Solving01:17

Rolling Resistance: Problem Solving

Rolling resistance, also known as rolling friction, is the force that resists the motion of a rolling object, such as a wheel, tire, or ball, when it moves over a surface. It is caused by the deformation of the object and the surface in contact with each other, as well as other factors like internal friction, hysteresis, and energy losses within the materials. Rolling resistance opposes the object's motion, requiring additional energy to overcome it and maintain movement. In practical...
Impact: Problem Solving01:26

Impact: Problem Solving

In an experiment conducted during a Mars mission, a rover propels a projectile with an initial velocity, and the projectile rebounds after colliding with the Martian surface. To ascertain the maximum height attained by the projectile after this collision, the known restitution coefficient and acceleration due to gravity are employed.
By designating the launch point as the origin and utilizing kinematic equations, the vertical component of the projectile's velocity at the point of impact is...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can LDL cholesterol be too low? Possible risks of extremely low levels.

Journal of internal medicine·2017
Same author

Macrophage erythrophagocytosis and iron exocytosis.

Redox report : communications in free radical research·2016
Same author

HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010
Same author

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Journal of internal medicine·2010
Same author

Well-being in patients with amyotrophic lateral sclerosis and their next of kin over time.

Acta neurologica Scandinavica·2009
Same author

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

International journal of clinical practice·2009
Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026
Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026
Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026
Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026
Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026
Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Artificial Intelligence-Based System for Detecting Attention Levels in Students
06:37

Artificial Intelligence-Based System for Detecting Attention Levels in Students

Published on: December 15, 2023

Addressing the challenge

A G Olsson1

  • 1Clinical Research Centre, University Hospital, Linköping, Sweden.

European Heart Journal
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Atorvastatin significantly lowers cholesterol and triglycerides, reducing coronary heart disease risk more effectively than other statins. It offers enhanced efficacy and a similar safety profile, achieving treatment goals at a lower cost.

More Related Videos

Examining Gesture Production in the Presence of Communication Challenges
07:18

Examining Gesture Production in the Presence of Communication Challenges

Published on: January 26, 2024

Construction of Out-of-Equilibrium Metabolic Networks in Nano- and Micrometer-Sized Vesicles
10:56

Construction of Out-of-Equilibrium Metabolic Networks in Nano- and Micrometer-Sized Vesicles

Published on: April 12, 2024

Related Experiment Videos

Last Updated: May 13, 2026

Artificial Intelligence-Based System for Detecting Attention Levels in Students
06:37

Artificial Intelligence-Based System for Detecting Attention Levels in Students

Published on: December 15, 2023

Examining Gesture Production in the Presence of Communication Challenges
07:18

Examining Gesture Production in the Presence of Communication Challenges

Published on: January 26, 2024

Construction of Out-of-Equilibrium Metabolic Networks in Nano- and Micrometer-Sized Vesicles
10:56

Construction of Out-of-Equilibrium Metabolic Networks in Nano- and Micrometer-Sized Vesicles

Published on: April 12, 2024

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypercholesterolemia increases coronary heart disease risk.
  • Lowering cholesterol effectively reduces coronary events.
  • Statins inhibit HMG-CoA reductase to lower lipids.

Purpose of the Study:

  • To evaluate the efficacy and safety of atorvastatin in lipid lowering.
  • To compare atorvastatin's lipid-lowering effects with other statins.
  • To assess atorvastatin's achievement of LDL-C treatment goals.

Main Methods:

  • Dose-dependent administration of atorvastatin (10-80 mg/day).
  • Comparison with other statins in the CURVES study.
  • Evaluation of lipid profiles including LDL-C, total cholesterol, triglycerides, and apolipoprotein B.

Main Results:

  • Atorvastatin dose-dependently reduced LDL-C (41-61%) and triglycerides (23-45%).
  • Atorvastatin demonstrated greater reductions in LDL-C, total cholesterol, apolipoprotein B, and triglycerides compared to other statins.
  • More patients achieved LDL-C goals with atorvastatin, often at a lower cost.

Conclusions:

  • Atorvastatin exhibits superior lipid-lowering efficacy compared to other statins.
  • Atorvastatin shares a comparable safety profile with other statins.
  • Atorvastatin is an effective and cost-efficient option for managing hypercholesterolemia.